Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 204
Filter
2.
AMA J Ethics ; 21(12): E1059-1064, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31876470

ABSTRACT

Gene editing, because it is a new technology, presents challenges to health care organizations' risk managers. At this time, little claims data exists upon which to make informed decisions about loss control and to draw upon when developing risk mitigation strategies. This article explores gene editing through the eyes of risk managers and underwriters and concludes that traditional risk management tools must be used to reduce risk until more is known about the frequency and severity of claims.


Subject(s)
Gene Editing/ethics , Risk Management/ethics , Gene Editing/methods , Genetic Therapy/adverse effects , Genetic Therapy/ethics , Genetic Therapy/methods , Humans , Insurance, Health/ethics , Risk Assessment , Risk Management/methods , Risk Management/organization & administration
3.
Schmerz ; 33(5): 466-470, 2019 Oct.
Article in German | MEDLINE | ID: mdl-31478143

ABSTRACT

Since the adoption of the law of March 6, 2017, any German physician can prescribe medical cannabis flowers and cannabis-based magistral and finished medicinal products. No specific indications for prescriptions are provided in the law. The statutory health insurance companies bear the costs once an application for cost coverage has been approved by the Medical Service of the Health Funds. The German associations of psychiatry (child, adolescents, and adults), neurology, palliative care, addictology, and pain medicine are watching these developments in the media, politics, and medical world with concern due to: the option to prescribe cannabis flowers despite the lack of sound evidence and against the recommendations of the German Medical Association; the lack of distinction between medical cannabis flowers and cannabis-based magistral and finished medical products; the indiscriminately positive reports on the efficacy of cannabis-based medicines for chronic pain and mental disorders; the attempts by the cannabis industry to influence physicians; the increase in potential indications by leaders of medical opinion paid by manufacturers of cannabis-based medicines. The medical associations make the following appeal to journalists: To report on the medical benefits and risks of cannabis-based medicines in a balanced manner. To physicians: to prescribe cannabis-based medicines with caution; to prefer magistral and finished medicinal products over cannabis flowers. To politicians: to consider data according to the standards of evidence-based medicine when making decisions and provide financial support for medical research into cannabis-based medicines.


Subject(s)
Cannabis , Chronic Pain , Insurance, Health , Journalism , Medical Marijuana , Politics , Practice Patterns, Physicians' , Chronic Pain/drug therapy , Germany , Humans , Insurance, Health/ethics , Insurance, Health/standards , Medical Marijuana/therapeutic use , Physicians/ethics , Physicians/standards , Practice Patterns, Physicians'/ethics , Practice Patterns, Physicians'/standards
4.
Hastings Cent Rep ; 49(4): 2, 2019 07.
Article in English | MEDLINE | ID: mdl-31429961

ABSTRACT

Over email a few days after the death of Daniel Callahan, cofounder of The Hastings Center and for many years its director and then president, Joseph Fins, a longtime Hastings colleague, offered this comfort: "[H]enceforth every issue of the Report is a living memorial to Dan the writer, editor, and institution builder." In the Hastings Center Report's first issue, published in June 1971, Dan stated, "To say that [the work of the Report] must be multi-disciplinary is only to say the issues [it will address] are as complex as human beings themselves." This July-August 2019 issue continues the tradition Dan began. An essay by Laura Guidry-Grimes expands on the importance of interdisciplinary conversations and problem solving-and attends to the complexity of human beings-in recalling a patient who was failed by multiple social institutions. In the lead article, a team of authors led by James Sabin identifies a challenge to conducting ethical research within learning health organizations, where research and care are integrated with the aid of patient data from health insurance providers.


Subject(s)
Ethicists , Interdisciplinary Communication , Problem Solving , Social Welfare , Humans , Insurance, Health/ethics , Organizational Culture
5.
Eur J Health Econ ; 20(9): 1317-1333, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31407102

ABSTRACT

In this paper, I analyze whether premium refunds can reduce ex-post moral hazard behavior in the health insurance market. I do so by estimating the effect of these refunds on different measures of medical demand. I use panel data from German sickness funds that cover the years 2006-2010 and I estimate effects for the year 2010. Applying regression adjusted matching, I find that choosing a tariff that contains a premium refund is associated with a significant reduction in the probability of visiting a general practitioner. Furthermore, the probability of visiting a doctor due to a trivial ailment such as a common cold is reduced. Effects are mainly driven by younger (and, therefore, healthier) individuals, and they are stronger for men than for women. Medical expenditures for doctor visits are also reduced. I conclude that there is evidence that premium refunds are associated with a reduction in ex-post moral hazard. Robustness checks support these findings. Yet, using observable characteristics for matching and regression, it is never possible to completely eliminate a potentially remaining selection bias and results may not be interpreted in a causal manner.


Subject(s)
Insurance Coverage , Insurance, Health/ethics , Morals , Empirical Research , Female , Germany , Humans , Male
6.
Int J Equity Health ; 18(1): 92, 2019 06 17.
Article in English | MEDLINE | ID: mdl-31208413

ABSTRACT

BACKGROUND: Fair financial contribution in healthcare financing is one of the main goals and challengeable subjects in the evaluation of world health system functions. This study aimed to investigate the equity in healthcare financing in Shiraz, Iran in 2018. MATERIALS AND METHODS: This was a cross- sectional survey conducted on the Shiraz, Iran households. A sample of 740 households (2357 persons) was selected from 11 municipal districts using the multi-stage sampling method (stratified sampling method proportional to size, cluster sampling and systematic random sampling methods). The required data were collected using the Persian format of "World Health Survey" questionnaire. The collected data were analyzed using Stata14.0 and Excel 2007. The Gini coefficient and concentration and Kakwani indices were calculated for health insurance premiums (basic and complementary), inpatient and outpatient services costs, out of pocket payments and, totally, health expenses. RESULTS: The Gini coefficient was obtained based on the studied population incomes equal to 0.297. Also, the results revealed that the concentration index and Kakwani index were, respectively, 0.171 and - 0.125 for basic health insurance premiums, 0.259 and - 0.038 for health insurance complementary premiums, 0.198 and - 0.099 for total health insurance premiums, 0.126 and - 0.170 for outpatient services costs, 0.236 and - 0.061 for inpatient services costs, 0.174 and - 0.123 for out of pocket payments (including the sum of costs related to the inpatient and outpatient services) and 0.185 and - 0.112 for the health expenses (including the sum of out of pocket payments and health insurance premiums). CONCLUSION: The results showed that the healthcare financing in Shiraz, Iran was regressive and there was vertical inequity and, accordingly, it is essential to making more efforts in order to implement universal insurance coverage, redistribute incomes in the health sector to support low-income people, strengthening the health insurance schemes, etc.


Subject(s)
Health Expenditures/ethics , Health Expenditures/statistics & numerical data , Healthcare Financing/ethics , Insurance Coverage/ethics , Insurance, Health/ethics , Universal Health Insurance/ethics , Universal Health Insurance/statistics & numerical data , Cross-Sectional Studies , Female , Humans , Insurance Coverage/statistics & numerical data , Insurance, Health/statistics & numerical data , Iran , Male
7.
AMA J Ethics ; 21(1): E93-99, 2019 01 01.
Article in English | MEDLINE | ID: mdl-30672425

ABSTRACT

Nearly 7% of US citizens born each year have at least one undocumented parent, but many pregnant undocumented immigrants are ineligible for public insurance covering prenatal care due to their immigration status. This article reviews national-level and state-level policies affecting access to prenatal care for members of this population. This article also considers ethical challenges posed by some policies that create obstacles to patients' accessing health care that is universally recommended by professional guidelines.


Subject(s)
Health Services Accessibility/ethics , Patient Advocacy/ethics , Physicians/ethics , Prenatal Care/ethics , Undocumented Immigrants , Female , Health Policy , Humans , Insurance, Health/ethics , Insurance, Health/organization & administration , Pregnancy , United States
8.
Urologe A ; 57(7): 798-803, 2018 Jul.
Article in German | MEDLINE | ID: mdl-29797023

ABSTRACT

BACKGROUND: This article describes the introduction of the law to combat corruption in the healthcare system. OBJECTIVE: The effects of the introduced penal regulations on the delivery of medical services is critically scrutinized and the associated procedures as well as indications for the course of action are presented. RESULTS: Knowledge of the relevant regulations and types of procedure is decisive for the penal, social legislative and professional conduct risk minimization.


Subject(s)
Conflict of Interest/legislation & jurisprudence , Fraud/ethics , Fraud/legislation & jurisprudence , Fraud/prevention & control , Insurance, Health/ethics , Physicians/ethics , Professional Misconduct/legislation & jurisprudence , Delivery of Health Care , Humans
10.
Contraception ; 96(5): 370-377, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28801054

ABSTRACT

OBJECTIVE: Following the 2016US presidential election, social media posts and news stories amplified concerns about the potential for reduced access to contraception under the incoming administration and urged women to seek long-acting reversible contraception. We aimed to describe women's concerns about future access to contraception, in their own words. STUDY DESIGN: A social-media-based, anonymous online survey assessing thoughts and concerns about future access to contraception was distributed to reproductive-aged US women for 1 week in mid-January 2017. Participants who were concerned about future access to contraception could share their thoughts and feelings in an open-ended comments box. We qualitatively analyzed 449 written responses for content and themes, with the goal of characterizing key concerns. RESULTS: Women who provided written comments had a mean age of 28years; 85% were white, 88% had at least a college degree, and 93% identified as Democratic or Democratic-leaning. Women were highly concerned about future affordability of contraceptive methods due to potential loss of insurance, reduced insurance coverage for contraceptive methods and reduced access to low-cost care at Planned Parenthood. Many also worried about increased restrictions on abortion. Participants' concerns regarding access to contraception and abortion centered around themes of reproductive and bodily autonomy, which women described as fundamental rights. CONCLUSIONS: Women in this study expressed considerable fear and uncertainty regarding their future access to contraception and abortion following the 2016US presidential election. The potential for restricted access to affordable contraception and abortion was viewed as an unacceptable limitation on bodily autonomy. IMPLICATIONS: As the future of US health care policy is debated, many women are concerned about the impact of policy changes on their ability to access affordable contraception and abortion, which many view as essential to the preservation of bodily and reproductive autonomy.


Subject(s)
Contraception , Democracy , Health Services Accessibility , Personal Autonomy , Politics , Social Change , Stress, Psychological/etiology , Abortion, Legal/ethics , Abortion, Legal/psychology , Adult , Attitude to Health , Contraception/ethics , Contraception/psychology , Contraceptive Prevalence Surveys , Female , Health Policy/trends , Health Services Accessibility/ethics , Health Surveys , Humans , Insurance Coverage/ethics , Insurance, Health/ethics , Internet , Reproductive Rights/ethics , Reproductive Rights/psychology , Stress, Psychological/psychology , United States , Women's Health Services/ethics , Young Adult
11.
J Orthop Sports Phys Ther ; 47(7): 503-508, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28622485

ABSTRACT

Synopsis Whiplash is a compensable injury in many jurisdictions, but there is considerable heterogeneity in the compensation arrangements that apply across jurisdictions, even within some countries. These compensation schemes have, however, been subject to a common set of interrelated concerns, chiefly concerning the incentives, behaviors, and outcomes that may arise when financial compensation for injuries is available to injured parties. This article provides a nontechnical overview of some of those concerns through the lens of economics: principally, insurance economics and health economics, including related subsets such as information economics and agency theory, as well as economics and the law. It notes that because it is generally infeasible to randomize the treatment (ie, compensation) via trials, analyses of observational data are necessary to discover more about the relationship between compensation and health outcomes. This poses the analytical challenge of discovering causal connections between phenomena from nonrandomized data sets. The present article calls for further research that would enable convincing causal interpretations of such relationships via the careful analysis of rich observational data sets using modern econometric methods. J Orthop Sports Phys Ther 2017;47(7):503-508. Epub 16 Jun 2017. doi:10.2519/jospt.2017.7533.


Subject(s)
Accidents, Traffic/economics , Disabled Persons/rehabilitation , Insurance, Health , Whiplash Injuries/economics , Whiplash Injuries/rehabilitation , Compensation and Redress/ethics , Compensation and Redress/legislation & jurisprudence , Disability Evaluation , Disabled Persons/psychology , Humans , Insurance, Health/ethics , Motivation , Whiplash Injuries/diagnosis , Whiplash Injuries/psychology , Workers' Compensation
15.
Kennedy Inst Ethics J ; 27(4): 561-587, 2017.
Article in English | MEDLINE | ID: mdl-29307881

ABSTRACT

While citizens in a liberal democracy are generally expected to see to their basic needs out of their own income shares, health care is treated differently. Most rich liberal democracies provide their citizens with health care or health care insurance in kind. Is this "special" treatment justified? The predominant liberal account of justice in health care holds that the moral importance of health justifies treating health care as special in this way. I reject this approach and offer an alternative account. Health needs are not more important than other basic needs, but they are more unpredictable. I argue that citizens are owed access to insurance against health risks to provide stability in their future expectations and thus to protect their capacities for self-determination.


Subject(s)
Health Services Accessibility/ethics , Insurance, Health/ethics , Human Rights , Humans , Policy Making
16.
BMC Med ; 14: 75, 2016 May 11.
Article in English | MEDLINE | ID: mdl-27170046

ABSTRACT

Priority setting is inevitable on the path towards universal health coverage. All countries experience a gap between their population's health needs and what is economically feasible for governments to provide. Can priority setting ever be fair and ethically acceptable? Fairness requires that unmet health needs be addressed, but in a fair order. Three criteria for priority setting are widely accepted among ethicists: cost-effectiveness, priority to the worse-off, and financial risk protection. Thus, a fair health system will expand coverage for cost-effective services and give extra priority to those benefiting the worse-off, whilst at the same time providing high financial risk protection. It is considered unacceptable to treat people differently according to their gender, race, ethnicity, religion, sexual orientation, social status, or place of residence. Inequalities in health outcomes associated with such personal characteristics are therefore unfair and should be minimized. This commentary also discusses a third group of contested criteria, including rare diseases, small health benefits, age, and personal responsibility for health, subsequently rejecting them. In conclusion, countries need to agree on criteria and establish transparent and fair priority setting processes.


Subject(s)
Health Priorities , Health Services Administration , Insurance, Health , Universal Health Insurance/ethics , Cost-Benefit Analysis , Female , Health Services Administration/economics , Health Services Administration/ethics , Humans , Insurance, Health/economics , Insurance, Health/ethics , Male , Morals , Socioeconomic Factors
18.
J Vasc Surg ; 63(4): 1108-9, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27016860

ABSTRACT

Dr F. Inest practices surgery at a renowned medical center but is concerned because increasing numbers of medical insurers are excluding his institution from coverage. Many of his former referring physicians are beginning to send their patients elsewhere for this reason. The marketing people have been busy increasing their advertising buys and exploring new business models. There is even talk about reducing expensive clinical trials. However, regardless of his affiliation, he has little control over these and other organizational decisions that directly impact his practice clinically and fiscally. What should he do?


Subject(s)
Academic Medical Centers/economics , Delivery of Health Care/economics , Health Care Costs , Health Services Accessibility/economics , Insurance Coverage/economics , Insurance, Health, Reimbursement/economics , Insurance, Health/economics , Referral and Consultation/economics , Academic Medical Centers/ethics , Advertising/economics , Conflict of Interest/economics , Delivery of Health Care/ethics , Health Care Costs/ethics , Health Services Accessibility/ethics , Humans , Insurance Coverage/ethics , Insurance, Health/ethics , Insurance, Health, Reimbursement/ethics , Marketing of Health Services/economics , Referral and Consultation/ethics
19.
Hist Cienc Saude Manguinhos ; 23(1): 211-20, 2016.
Article in English | MEDLINE | ID: mdl-27008082

ABSTRACT

An interview with Charles Rosenberg conducted by Rafael Mantovani in November 2013 that addressed four topics. It first focused on the way in which Rosenberg perceived trends and directions in historical research on medicine in the United States during the second half of the twentieth century. The second focus was on his experience with other important historians who wrote about public health. Thirdly, he discussed his impressions about the current debate on health policy in his country. Finally, the last part explores some themes related to psychiatry and behavior control that have appeared in a number of his articles.


Subject(s)
Health Policy , History of Medicine , Historiography , History, 20th Century , History, 21st Century , Insurance, Health/ethics , Psychiatry/history , Public Health , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...